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センター長 小松かっ子 Chief of Center Katsuko Komatsu (Ph.D.) 
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く〉研究目的 Aims of the research projects 
世界各地の民族薬物に関する資料の収集及び整理，薬効の評価及び解析並びにデータベースの構
築を行い，世界の伝統薬物及び薬用植物に関する共同研究を推進する。












18S rRNA 遺伝子及び trnK 遺伝子の塩基配列に基づく同定法として， Cureumα 属植物及び欝金類生薬に
ついては SNPs 解析法，人参類生薬については Multiple Amplification-refractory Mutation System 法
を確立した。
2 ）生薬の基源と品質に関する研究
大黄の成分組成パターンは， mαtK 遺伝子の多型に基づいた薬用 Rheum 属植物の分類と関連性があること
を明らかにした。穆金類生薬 5 種及びそれぞれの主成分の血管弛緩作用を明らかにした。日本産ガジュツ cc.
zedoαriα）の熱水抽出エキスのみ NO 依存性の弛緩作用も認められ，これは多糖類に起因するものであった。
IV. 世界の伝統医薬学の調査研究
漢薬の資源をアジアに探る研究の一環として，モンゴル国のウランパートル～西部一帯で、 Astrαgal us 属，
Ephedra 属， Glycyrrhizα 属植物などの植生調査を行った。
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く〉著書 Book
1) Komatsu K.: Authentication based on 18S ribosomal RNA gene and matK gene sequences. ”Authentication 
of Chinese Medicinal Materials by DNA Technology,'’ edited by Shaw P.C., Wang J., and But P.P.H., World 
Scientific Publishing, Singapore, 2002, pp.193・212.
2 ）小松かっ子，伏見裕利：「和漢薬の事典J 難波恒雄監修，富山医科薬科大学和漢薬研究所編， 419pp，朝
倉書店，東京， 2002.
く〉原著 Original paper 
1 ) Zou K., Zhu S., Tohda C., Cai S. Q. and Komatsu K. : Dammarane-type triterpene saponins 
from Panax japonicus. J. Nat. Prod., 65 : 346・351, 2002. 
Abstract : Six new dammarane-type saponins ( 1-6), together with 1 known saponins (7-17), were isolated from Yeｭ
Sanchi, the underground part of Panax japonicus collected in the south of Yunnan Province, China. Their structures 
were elucidated by chemical and spectroscopic means. 
2) Zou K., Zhu S., Meselhy M. R., Tohda C., Cai S. Q. and Komatsu K. : Dammarane-type 
saponins from Panax japonicus and their neurite outgrowth activity in SK-N・SH cells. J. Nat. 
Prod., 65: 1288・1292, 2002. 
Abstract : Four new dammarane-type saponins ( 1-4 ),named yesanchinosides G-J, together with nine ginsenosides 
(5-13) were isolated from Ye-Sanchi, the underground part of Panax japonicus collected in the south of Yunnan 
Province, China. Their structures were elucidated on the basis of spectroscopic and chemical methods. Ginsenosides 
Rb1 and Rb3 and notoginsenosides R4 (6) and Fa (7) showed significant neurite outgrowth enhancing activities in 
human neuroblastoma SK-N-SH cels. 
3 ）難波恒雄，鐘国躍，伏見裕利，小松かっ子：正倉院薬物「鬼臼」の基源について．和漢医薬学
雑誌 19: 181・188, 2002. 
Abstract :”Kikyu (Guijiu)” described in Shinnou-honzoukyo (Shennong-bencaojing) is generally considered to be 
the same drug as Hakkakuren (Bajiaolian) in the present market, and mainly derived from the rhizomes of Dysosma 
versipellis and D. pleiantha of Berberidaceae. However, the drug preserved in Shosoin, to be assumed as ”Guijiu,” 
has been reported to be similar to monocotyledon plants, particularly to the rhizome of Hosta plants of Liliaceae in 
the internal structures. In this paper, in order to further clarify the botanical origin of ”Guijiu” in Shosoin, we comｭ
pared its anatomical characteristics with those of underground parts of two Hosta species (H. plantaginea and H. 
ventricosa) from Jiangsu, Guizhou and Sichuan provinces of China. As the result, we have demonstrated that the 
drug ”Guijiu” in Shosoin was derived from the underground part of H. plantaginea. 
4 ) Tohda C., Matsumoto N., Zou K., Meselhy M. R. and Komatsu K. : Axonal and dendrite exｭ
tension by protopanaxadiol-type saponins from Ginseng drugs in SK-N-SH cells. Jpn. J. 
Pharmacol., 90 : 254・262, 2002. 
Abstract : Extension of axons and dendrites in neurons may compensate for and repair damaged neuronal networks 
in the dementia brain. To find out drugs capable of regenerating the neuronal network, we focused on several herbal 
drugs belonging to the genus Panax, kinds of Ginseng, and investigated neurite outgrowth activity of their extracts 
and compounds. We found that the methanol extracts of Ginseng (root of P. ginseng), Notoginseng (root of P. 
notoginseng) and Ye-Sanchi in Chinese (rhizome of a relative to P. νietnamensis) increased neurite outgrowth in SKｭ
N-SH cels. The protopanaxadiol-type saponins, ginsenosides Rb1 and Rb3, and notoginsenosides R4 and Fa isolated 
from Y e-Sanchi extract extended neurites, while protopanaxatriol-, ocotillol-and oleanane-type saponins had no efｭ
feet on the neurite outgrowth. The percentage of cells with multipolar neurites and number of varicosities were 
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intensely high in cells treated with the methanol extract of Ye-Sanchi as well as ginsenosides Rb1 and Rb3, and 
notoginsenosides R4 and Fa. Both phosphorylated NF-H-expressing neurites and MAP2-expressing ones were exｭ
tended by treatment with those saponins and the extract. Especially, longer neurites were mainly positive for 
phosphorylated NF-H. These results suggest that protopanaxadiol-type saponins enhance axonal and dendritic formaｭ
tion activity. 
5) Kuboyama T., Tohda C., Zhao J., Nakamura N., Hattori M. and Komatsu K.: Axon-or denｭ
drite-predominant outgrowth induced by constituents from Ashwagandha. NeuroReport, 13: 
1715・1720, 2002. 
Abstract : We previously reported that the methanol extract of Ashwagandha (roots of Withania somnifera Dunal) 
induced dendrite extension in a human neuroblastoma cel line. In this study, we found that six of the 18 compounds 
isolated from the methanol extract enhanced neurite outgrowth in human neuroblastoma SH-SY5Y cels. Double 
immunostaining was performed in rat cortical neurons using antibodies to phosphorylated NF・H as an axonal 
marker, and to MAP2 as a dendritic marker. In withanolide A-treated cels, the length of NF-H-positive processes 
was significantly increased compared with vehicle-treated cels, whereas, the length of MAP2-positive processes was 
increased by withanosides IV and VI. These results suggest that axons are predominantly extended by withanolide 
A, and dendrites by withanosides IV and VI. 
6) Zhao J., Nakamura N., Hattori M., Kuboyama T., Tohda C. and Komatsu K. : Five new 
withanolide derivatives from the roots of Withania somnifera. Chem. Pharm. Bull., 50: 760・
765, 2002. 
Abstract : Five new withanolide derivatives (1, 9-12) were isolated from the roots of Withania somnifera together 
with fourteen known compounds (2-8, 13-19). On the basis of spectroscopic and physiochemical evidence, comｭ
pounds 1 and 9-12 were determined to be (20S,22R)-3α，6α－epoxy-4β，5β，27-trihydroxy-1 ・oxowitha-24-enolide (1), 
27-0－β－o-glucopyranosylpubesenolide 3-0－β－D-glucopyranosyl (1→6）ーβ－o-glucopyranoside (withanoside VIII, 9), 
27-0－β－o-glucopyranosyl (1→6）ーβ－o-glucopyranosylpubesenolide 3・0－β－o-glucopyranosyl (1→6）ーβ－o-glucopyranoside
(withanoside IX, 10), 27-0－β－o-glucopyranosylpubesenolide 3-0－β－o-glucopyranoside (withanoside X, 1), and (20 
S,22R）ー lα ，3β，20:27-tetrahydroxywitha-5,24・dienolide 3-0－βーn-glucopyranoside (withanoside XI, 12). Of the isoｭ
lated compounds, 1, withanolide A (2), (20S,22R)-4/3,5/3,6α ，27-tetrahydroxy-1-oxowitha-2,24-dienolide (6), withanoside 
IV (14 ),withanoside VI (15) and coagulin Q (16) showed signi白cant neurite outgrowth activity at a concentration 
of 1 ｵM on a human neuroblastoma SH-SY5Y cel line. 
7 ) Sasaki Y .,Fushimi H., Cao H., Cai S. Q. and Komatsu K. : Sequence Analysis of Chinese and 
Japanese Curcuma Drugs on the 18S rRNA Gene and trnK Gene and the Application of 
Amplification胴Refractory Mutation System Analysis for Their Authentication. Biol. Pharm. 
Bull., 25: 1593-1599, 2002. 
Abstract : The botanical origins of Chinese and Japanese Curcuma drugs were determined to be Curcuma longa, 
C. phaeocaulis, the Japanese population of C. zedoaria, C. kwangsiensis, C. wenyujin, and C. aromatica based on 
a comparison of their 18S rRNA gene and trnK gene sequences with those of six Curcuma species reported previｭ
ously. Moreover, to develop a more convenient identification method, amplification-refractory mutation system 
(ARMS) analysis of both gene regions was perfo口ned on plants. The ARMS method for the 18S rRNA gene was 
established using two types of forward primers designed based on the nucleotide difference at position 234. When 
DNAs of four Curcuma species were used as templates, PCR amplification with either of the two primers only genｭ
erated a fragment of 912 base pairs (bp). However, when DNAs of the purple-cloud type of C. kwangsiensis and C. 
wenyujin were used, PCR amplifications with both primers unexpectedly generated the fragment, suggesting that 
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these two were heterozygotes. The ARMS method for the tmK gene was also established using a mixture of four 
types of specific reverse primers designed on the basis of base substitutions and indels among six species, and comｭ
mon reverse and forward primers. C. phaeocaulis or the Chinese population of C. zedoaria, the Japanese population 
of C. zedoaria or the purple-cloud type of C. kwangsiensis, the pubescent type of C. kwangsiensis or C. wenyujin, 
and C. aromatica were found to show specific fragments of 730, 185, 527 or 528, and 641 or 642 bp, respectively. 
All species including C. longa also showed a common fragment of 897-904 bp. Using both ARMS methods, together 
with information on producing areas, the identification of Curcuma plants was achieved. Moreover, the ARMS 
method for the tmK gene was also useful for authentication of Curcuma drugs. 
8) Ma C. M., Nakamura N., Miyashiro H., Hattori M., Komatsu K., Kawabata T. and Otake T.: 
Screening of Chinese and Mongolian Herbal Drugs for Antihuman Immunodeficiency Virus 
Type 1 (HIV・1) Activity. Phytother. Res., 16: 186・189, 2002. 
Abstract : Water and methanol extracts of 30 Chinese and Mongolian medicinal plants were tested for their human 
immunodeficiency virus type-1 (HIV-1) inhibitory activity. Of the 60 extracts, 23 showed anti-HIV activity. 
Bioassay-guided fractionation of one of the most active extracts, the methanol extract of the root tuber of Stephania 
cepharantha, led to the isolation of two alkaloids, aromoline and FK-3000 as potent inhibitory substances. They 
completely inhibited the cytopathic effects of HIV-1 on MT-4 cells at 31.3 and 7.8 microg/mL, respectively. 
9 )Takahashi K., Ouyang X., Komatsu K., Nakamura N., Hattori M., Baba A •. and Azuma J. : 
Sodium tanshinone HA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates byｭ
pertrophy induced by angiotensin I in cultured neonatal rat cardiac cells. Biochem. Pharmacol., 
64: 745・749, 2002. 
Abstract : Sodium tanshinone IIA sulfonate (STS), a derivative of tanshinone IIA, is isolated from the root of Salvia 
miltiorrhiza known as ”Danshen.” Although i吋ection of S. miltiorrhiza extract and STS is used widely and successｭ
fully in clinics in China for treating cardiovascular diseases, the exact mechanism for its therapeutic basis is poorly 
understood. The present study was undertaken to characterize the effect of STS on angiotensin II-induced hypertroｭ
phy on cultured myocytes and cardiac fibroblasts (nonmyocytes) prepぽ·ed from neonatal rat hearts. Angiotensin I 
(1 nM) increased protein synthesis and surface area in myocytes, and DNA synthesis and cel number in 
nonmyocytes, respectively. Exposure of the myocytes to STS (5-80 ｵM) for 24hr produced no cytotoxicity as evaluｭ
ated by the 3-[4,5-dimethylthiazol-2-yl]-3,5-diphenylformazan (MTT) assay. Although STS (10 ｵM) alone showed 
no effect on the growth of cultured cardiac cels, it markedly suppressed angiotensin II-induced enlargement of cells 
and [3H]phenylalanine inco中oration, proceeding from the induction of immediate early gene (cゾun) expression in 
myocytes. Furthermore, STS prevented the rise in [Ca2+](i) mediated by angiotensin I in myocytes. In contrast, STS 
(10 ｵM) was without effect on hyperplasia and c-jun expression induced by angiotensin I in nonmyocytes. The preｭ
sent in vitro findings support the interpretation that STS is a substance that may be beneficial in protecting the myoｭ
cardium against hypertrophy. 
10）高橋京子，花谷忠昭，渡遺麻里子，高谷朋夏，小松かっ子，高橋幸一，東純一．：中国伝統医
薬の薬物相互作用について：丹参製剤に含有される CYP 代謝阻害物質の探索．臨床薬理学雑




な CYP 分子種について， ヒト肝ミクロソーム（Ms）を用い丹参の影響を検討した。
【方法】丹参として中国薬典に規定されている Salviα miltiorr・hiza (SM）と，中国市場品から同定された S.
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przewαlskii: SP ；および S. yunnαnensis: SY を用いた。これらの根から各エキ又を調製し，主要成分の含
量を HPLC 法により定量した。各成分および丹参注射剤（Tanshinone sulfonate: STS 剤）の作用は， Ms
を用い， P450分子種のモデル基質代謝に対する活性阻害として検出した。
【結果・考察】水溶性 SM2 (40 microg/mL）は 3A4, 2C9 および 1A2 代謝活性を 32-42% 阻害した。 SM2
に 60% 含有される Lithospermic acid B:LSB は， これらの代謝に影響しなかった。 MeOH 可溶性 SP3 (40 
microg/mL）は 1A2 を 70% 阻害したが， SM3 では 18% で基原植物により阻害強度が異なった。 EtOAc 可
溶性 SM4 Cl-40 microg/mL）は濃度依存的に 2C9 及び 1A2 代謝を強く間害したが， 2D6 には影響しなかっ
た。 1A2 阻害は Tanshinone IIA (TS）含量が高い SP4 が最も強く， TS の Ki 値は 0.7 microM であった。
TS の誘導体・ STS 注射剤は 2C9 を非競合的に阻害した（Ki=4 microM）。今回，丹参由来成分が 2C9, 1A2 
を強く阻害することを明らかにした。 S 体ワルファリンは主に 2C9 で代謝されるため，丹参との併用により相
互作用が生じる可能性がある。
11) Liu Y. P., Cao H., Han G. R., Fushimi H. and Komatsu][{.: matK and its nucleotide sequenc・
ing of crude drug Chuanxiong and phylogenetic relattionsh1p between their species from 
China and Japan. Acta Pharmaceutica Sinica, 37 : 63-68, 2002. 
Abstract: AIM: To provide more molecular evidences for species relationship between Chuanxiong (Ligusticum 
chuanxiong Hort.) from China and Japanese Chuanxiong (Senkyu in Japanese) (Cnidium officinale Makino). 
METHOD: To sequence such two genes as internal transcribed spacer (ITS) from nuclear rDNA and maturase for 
lysine (matK) in tRNAlys (UUU) intron from chloroplast DNA of both Ligusticum chuanxiong and Cnidium 
Qがcinale using PCR direct sequencing and to analyze the sequence variation of two genes between these two speｭ
cies. RESULT: The matK gene sequence of Ligusticum chuanxiong and Cnidium officinale is 1268 bp in length, 
coding 422 amino acids of maturase protein. ITS gene sequence 699 bp, consisting of 54 bp of 18S rRNA-3', 215 
bp of ITSI, 162 bp of 5.8S rRNA, 222 bp of ITS2, 46 bp of 26S rRNA-5'. Multiple sequence alignment shows that 
the sequence of two genes between dried crude drug and fresh vouch~r material of Ligusticum chuanxiong and 
Cnidium officinale, there is 1 variable site (T-C) in matK (upstream at 595 nt) and ITS (ITS 1 at54 nt) between 
Ligusticum chuanxiong and Cnidium officinale. CONCLUSION: Based on homology analysis of two genes plastid 
matK and nuclear ITSγthe origin of Chuanxiong from China and Japan ought to be identical, the scientific name 
Cnidium officinale of Japanese Chuanxiong should be changed to Ligus.ticum chuanxiong. 
く〉学会報告 Scientific presentation 
1 ）東田千尋，小松かっ子：中枢神経細胞の軸索終末へ輸送される mRNA の解析．第75回日本薬理学会年
会， 2002, 3/13-15，熊本．
2 ）久保山友晴，東田千尋，服部征雄，小松かっ子：軸索あるいは樹状突起を優先的に伸展させるインド生
薬 Ashwagandha (Withαniα somniferα DunαJ の根）成分の解析．第75回日本薬理学会年会， 2002,
3/13-15，熊本．
3 ）高橋京子，小松かっ子，欧陽新収，松田貴久，程新耀，中村憲夫，服部征雄，東純一：心臓由来培養細
胞に対する丹参製剤の作用． 日本薬学会第122年会， 2002, 3/26-28，千葉．
4) 小松かっ子： Molecularanalysis of medicinally-used Curcumαplants and its application for the 
identification of related drugs. 中華民国生薬学会九十一年度第四回第二次会員大会・学術討論会
（特別講演）， 2002, 5/4，高雄（中華民国）．
5 ）久保山友晴，東田千尋，小松かっ子： Neurite outgrowth effects of withanolide A, withanoside IV 
and wi thanoside VI in Aβ25-35-induced atrophy of neurites. 第45回日本神経化学会， 2002, 7 I 
17-19，札幌
6 ）田村隆幸，東田千尋，小松かっ子： Therapeutic effects of Zokumei-to on spatial learning impairｭ





の検討．第10回医療薬学シンポジウム， 2002, 7 /6-7，千葉．
8 ）佐々木陽平，後藤博三，畠中史幸，柴原直利，寺津捷年，小松かっ子： Cureumα 属植物の分子系統学
的解析と穆金類生薬の品質に関する研究（2）－穆金類生薬の血管作動’性について．第19回和漢医薬学会
大会， 2002, 8/31-9/1，千葉．
9 ）小松かっ子，高橋京子， Basnet P.，劉玉津，渡遷麻里子，富森毅，宮一諭起範，東純一：黄ゴン市場





11）楊冬野，伏見裕利，察少青，小松かっ子： Rheum 属植物の分子系統学的研究（2)-mαtK 遺伝子と rbc
L 遺伝子の塩基配列．日本生薬学会第49回年会， 2002, 9/5-6，福岡．
12）小松かっ子，長山頼信， Meselhy M. R.，凌雲，察少青：大黄の基源と品質に関する研究－Rheum 属
の遺伝子多型との対比．日本生薬学会第49回年会， 2002, 9/5-6，福岡．
13）佐々木陽平，伏見裕利，小松かっ子： Curcumα 属植物の分子系統学的解析と穆金類生薬の品質に関す
る研究（3）－植物と生薬の SNPs 解析．日本生薬学会第49回年会， 2002, 9/5-6，福岡．
14) Zhu S.，伏見裕平IJ ，察少青，小松かっ子： Authentication of Ginseng Drugs by Multiple 
Amplification Refractory Mutation System (MARMS）.日本生薬学会第49回年会， 2002, 9 /5-6, 
福岡．
15）越静，中村憲夫，服部征雄，小松かっ子，楊秀偉，郎明華： Isolation and Structure Elucidation of 
New Triterpenoid Saponins from the Roots of Sinocrαssula αsclepiαdeα．日本生薬学会第49回年
会， 2002, 9/5-6，福岡．
16）西田裕子，高橋京子，上島悦子，小松かっ子，佐々木陽平，荒川行生，山本克己竹上学，片岡和三




ジー研究」研究成果報告書， pp. 28-31, 2002. 
2 ）小松かっ子：北伝アーユルヴェーダ～チベット医学とモンゴル医学. Aroma topia （特集生活に取り
入れるアーユルヴェーダ）， 52: 52-60, 2002. 
3 ）小松かっ子：分子生物学的手法を応用した生薬の同定．ファルマシア（特集生薬学・天然物化学， 21
世紀の百花練乱），セミナー， 38 : 841-845, 2002. 
4 ）東田千尋：カレースパイス成分のクルクミンがアルツハイマー痴呆を予防する．ファルマシア 38: 891-
892 2002. 
5 ）東田千尋：カッツング薬理学原書 8 版（翻訳分担） pp. 1209-1226, 2002. 
6 ）小松かっ子：神経突起伸展を誘導する伝統薬物の検討．平成13年度目本東洋医学会北陸支部特別講演会・
専門医制度夏季教育講演会， 2001, 7 /15，福井．













14) Komatsu K.: Molecular analysis of medicinally-used Curcuma plants and its application for the identification 
of related drugs. Core University Program, JSPS, 2002, 11113-29, Prince of Songkla Univ., Srinakharinwirot 
Univ. Thailand. 
く〉海外調査 Overseas research 
1 ）小松かっ子，伏見裕利，長部大地：漢薬の資源をアジアに探る：モンゴル及びタイ産薬用植物の調査研
究，文部省科学研究費基盤研究（B)(2), 2002, 7 /12-8/16，モンゴル国．
2 ）小松かっ子：伝統薬物資源の有効利用と再生を志向した薬用植物の多様性に関する研究，在外研究員
（創造開発研究）， 2002, 9/8-9/30，中国．




く〉共同研究 Co-operative researches 
J a vzan Ba tkh u u ：国立モンゴル大学生物学部
察少青：北京大学薬学院












く〉非常勤講師 Part-time teacher 
1 ）小松かっ子：金沢大学教養的科目（総合科目）「ヒマラヤ風土記J，第11回「中国ヒマラヤの自然、と文化」，
第12回「チベット医学と仏教」，第14回総合討論， 2002, 12/19 ; 2003, 1/16, 1/23，金沢．
























研究支援推進員：幸雅子，出口鳴美（2002, 9/1－），凌雲（2002, 4/1-8/31) 
外国人客員研究員：楊政哲（2002, 9 /10-9 /30) 







く〉民族薬物資料館記録 Archive of Museum of Materia Medica 
1 ）一般公開：平成14年11月 2 日に第 5 回の民族薬物資料館一般公開を実施した．予約制とし， 10時， 11時，
14時， 15時， 16時からの 5 回に分けて各1時間、生薬の解説を加えながら館内を案内した 13:00～13:50
に富山医科薬科大学・和漢薬研究所・薬効解析センター・助教授の小松かっ子による講演会「チベット
モンゴル薬草紀行」を行った．参加者は70名．
2 ）見学者記録（2002年 4 月 1 日～2003年 3 月 31 日）
来館者総数： 708名（日本人 639名，外国人 69名）
案内総回数： 133回（日本人 100回，外国人 33回）
外国人の国名（人数）：韓国（23），中国 (16），アメリカ（8），台湾，タイ（各 6), ミャンマー（3),
マレーシア，ベトナム（各 2），オーストリア (1），不明（2)
く〉民族薬物データベース記録 Record of TJle Data Base of Ethno-medicines in the World 
(ETHMEDmmm) (2002年 4 月 1 日～2003年 3 月 31 日）
アクセス数： 11937件（日本語ページ）， 1888件（英語ページ）
専門検索登録者数： 178名，専門検索アクセス数： 1884件
